Rh Incompatibility and Hemolytic Disease of the Newborn: Risks and Prevention
Rh HDN occurs when an Rh− mother is sensitized to Rh+ fetal RBCs (from current or prior pregnancy/transfusion) and produces anti‑D IgG that crosses the placenta → fetal hemolysis.
Pathway
- Fetomaternal hemorrhage (delivery, trauma, procedures) exposes Rh− mother to Rh+ cells.
- Maternal immune response → anti‑D IgG (crosses placenta).
- Anti‑D binds fetal Rh+ RBCs → extravascular hemolysis (spleen/liver).
- Fetal anemia → high‑output heart failure → hydrops fetalis (edema, ascites, pericardial effusion).
- Bilirubin ↑ → kernicterus (brain damage) if severe.
Prevention
- RhIg (RhoGAM): 300 μg IM at 28 weeks, within 72 hours post‑delivery (if baby Rh+), and after any sensitizing event (amnio, bleeding, trauma, ectopic, abortion).
- Blocks maternal recognition of Rh+ cells.
Management if Sensitized
- Serial maternal titers, MCA Doppler (fetal anemia surveillance).
- Intrauterine transfusion (IUT) if anemia.
- Early delivery if mature.
- Phototherapy/exchange transfusion for neonatal hyperbilirubinemia.
RhIg has reduced HDN incidence >99%. Universal Rh screening in pregnancy is standard.
Pregnancy & Health - Related Articles
- Pineapple and Pregnancy: Does It Induce Labor or Affect Duration?
- Swimming at 40 Weeks Pregnant: Safety Guidelines & Considerations
- Water Exercise During Pregnancy: Benefits & Safety Tips
- Alcohol in Early Pregnancy: No Safe Amount—Risks of Fetal Alcohol Spectrum Disorders
- Post‑Coital Wiping Does Not Prevent Pregnancy
- Early Pregnancy Sensations: Hiccups, Gas, and What They Mean
- Fluctuating Pregnancy Symptoms at 8–9 Weeks: Usually Normal, Not a Miscarriage Sign
